Cargando…

Clinical Performance and Analytical Sensitivity of Three SARS-CoV-2 Nucleic Acid Diagnostic Tests

Hundreds of RT-qPCR kits are available in the market for SARS-CoV-2 diagnosis, some of them with emergency use authorization (EUA) by the Food Drug Administration (FDA) or their country of origin agency, but also many of them without any independent clinical performance evaluation. We performed a cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freire-Paspuel, Byron, Garcia-Bereguiain, Miguel Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045661/ https://www.ncbi.nlm.nih.gov/pubmed/33635827 http://dx.doi.org/10.4269/ajtmh.20-1484

Ejemplares similares

Analytical sensitivity and clinical performance of a triplex RT-qPCR assay using CDC N1, N2, and RP targets for SARS-CoV-2 diagnosis
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

Analytical and Clinical Evaluation of Two RT-qPCR SARS-CoV-2 Diagnostic Tests with Emergency Use Authorization in Ecuador
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)"
por: Freire-Paspuel, Byron, et al.
Publicado: (2020)

Correction to: Poor sensitivity of "AccuPower SARS‑CoV‑2 real time RT‑PCR kit (Bioneer, South Korea)"
por: Freire‑Paspuel, Byron, et al.
Publicado: (2021)

Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CDC EUA as a Quality Control Proxy for Developing Countries
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

Analytical sensitivity and clinical performance of "COVID-19 RT-PCR Real TM FAST (CY5) (ATGen, Uruguay) and "ECUGEN SARS-CoV-2 RT-qPCR" (UDLA-STARNEWCORP, Ecuador)": High quality-low cost local SARS-CoV-2 tests for South America
por: Freire-Paspuel, Byron, et al.
Publicado: (2022)

Low clinical performance of the Isopollo COVID-19 detection kit (M Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: A call for action against low quality products for developing countries
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

Corrigendum to “Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis” [Virology volume (2021) 154–156]
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

SARS-CoV-2 infection in free roaming dogs from the Amazonian jungle
por: Zambrano-Mila, Marlon Steven, et al.
Publicado: (2022)

"Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit"
por: Freire-Paspuel, Byron, et al.
Publicado: (2020)

High sensitivity-low cost detection of SARS-CoV-2 by two steps end point RT-PCR with agarose gel electrophoresis visualization
por: Figueroa, Solange, et al.
Publicado: (2021)

Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies
por: Freire-Paspuel, Byron, et al.
Publicado: (2020)

Cotton-Tipped Plastic Swabs for SARS-CoV-2 RT-qPCR Diagnosis to Prevent Supply Shortages
por: Freire-Paspuel, Byron, et al.
Publicado: (2020)

Massive SARS-CoV-2 RT-PCR Testing on Rural Communities in Manabi Province (Ecuador) Reveals Severe COVID-19 Outbreaks
por: Ortiz-Prado, Esteban, et al.
Publicado: (2021)

Analytical and clinical evaluation of a heat shock SARS-CoV-2 detection method without RNA extraction for N and E genes RT-qPCR
por: Bruno, Alfredo, et al.
Publicado: (2021)

“One health" inspired SARS-CoV-2 surveillance: The Galapagos Islands experience
por: Freire-Paspuel, Byron, et al.
Publicado: (2020)

Corrigendum to: “One health” inspired SARS-CoV-2 surveillance: The Galapagos Islands experience [One Health 11 (2020) 100185]
por: Freire-Paspuel, Byron, et al.
Publicado: (2021)

Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection
por: Smith, Elizabeth, et al.
Publicado: (2020)

Analytical Performance Evaluation of Three Commercial Rapid Nucleic Acid Assays for SARS-CoV-2
por: Yi, Jie, et al.
Publicado: (2021)

COVID-19 outbreaks at shelters for women who are victims of gender-based violence from Ecuador
por: Vallejo-Janeta, Alexander Paolo, et al.
Publicado: (2021)

Clinical comparison of three SARS-CoV-2 nucleic acid amplification tests for routine diagnostic testing
por: Garmatiuk, Tetiana, et al.
Publicado: (2023)

Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital
por: Hohl, Corinne M., et al.
Publicado: (2022)

The quality of commercial SARS-CoV-2 nucleic acid tests in Ecuador: lessons from COVID-19 pandemic for advancing social equity through microbiology
por: Morales-Jadan, Diana, et al.
Publicado: (2023)

Equitable distribution of SARS-CoV-2 tests
por: Garcia-Bereguiain, Miguel Angel, et al.
Publicado: (2022)

High SARS-CoV-2 infection rates and viral loads in community-dwelling individuals from rural indigenous and mestizo communities from the Andes during the first wave of the COVID-19 pandemic in Ecuador
por: Morales-Jadán, Diana, et al.
Publicado: (2023)

First Report of SARS-CoV-2 Lineage B.1.1.7 (Alpha Variant) in Ecuador, January 2021
por: Carrazco-Montalvo, Andres, et al.
Publicado: (2021)

Comparison of three molecular diagnostic assays for SARS‐CoV‐2 detection: Evaluation of analytical sensitivity and clinical performance
por: Kim, Ha Nui, et al.
Publicado: (2022)

Clinical Performance of Three Commercial SARS‐CoV‐2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting
por: Morales-Jadán, Diana, et al.
Publicado: (2022)

Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
por: Uhteg, Katharine, et al.
Publicado: (2020)

High SARS-CoV-2 Infection Rates Among Special Forces Police Units During the Early Phase of the COVID-19 Pandemic in Ecuador
por: Ortiz-Prado, Esteban, et al.
Publicado: (2022)

Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update
por: Yu, Choo Yee, et al.
Publicado: (2021)

In response to: "Diagnostic evaluation of nCoV-QS, nCoV-QM-N, and nCoV-OM detection kits based on rRT-PCR for detection of SARS-CoV-2 in Ecuador"
por: Garcia-Bereguiain, Miguel Angel
Publicado: (2023)

Diagnostic performance of nucleic acid tests in tuberculous pleurisy
por: Han, Min, et al.
Publicado: (2020)

SARS-CoV-2 in river water: Implications in low sanitation countries
por: Guerrero-Latorre, Laura, et al.
Publicado: (2020)

Nucleic Acid Testing of SARS-CoV-2
por: Yoo, Hee Min, et al.
Publicado: (2021)

COVID-19 Community Transmission and Super Spreaders in Rural Villages from Manabi Province in the Coastal Region of Ecuador Assessed by Massive Testing of Community-Dwelling Population
por: Rodriguez-Paredes, Maria Belén, et al.
Publicado: (2022)

Multicenter evaluation of a simple and sensitive nucleic acid self-testing for SARS-CoV-2
por: Shen, Xin-Xin, et al.
Publicado: (2023)

Performances of four Nucleic Acid Amplification Tests for the identification of SARS-CoV-2 in Ethiopia
por: Hailemariam, Belete Woldesemayat, et al.
Publicado: (2022)

Homebrew: An economical and sensitive glassmilk-based nucleic-acid extraction method for SARS-CoV-2 diagnostics
por: Page, Robert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c31q91sbs8sbaffqat90b08q4j